Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1972 1
1973 1
1974 1
1975 1
1976 1
1977 4
1978 6
1979 2
1980 3
1981 5
1982 2
1983 3
1984 1
1985 1
1988 1
1990 2
1991 2
1993 2
1994 1
1996 1
1997 2
1998 3
1999 2
2001 2
2005 3
2006 2
2007 5
2008 4
2009 6
2010 7
2011 4
2012 4
2013 17
2014 20
2015 18
2016 33
2017 24
2018 18
2019 22
2020 22
2021 22
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

258 results
Results by year
Filters applied: . Clear all
Page 1
The Next Decade of Immune Checkpoint Therapy.
Sharma P, Siddiqui BA, Anandhan S, Yadav SS, Subudhi SK, Gao J, Goswami S, Allison JP. Sharma P, et al. Among authors: yadav ss. Cancer Discov. 2021 Apr;11(4):838-857. doi: 10.1158/2159-8290.CD-20-1680. Cancer Discov. 2021. PMID: 33811120 Review.
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Goswami S, Walle T, Cornish AE, Basu S, Anandhan S, Fernandez I, Vence L, Blando J, Zhao H, Yadav SS, Ott M, Kong LY, Heimberger AB, de Groot J, Sepesi B, Overman M, Kopetz S, Allison JP, Pe'er D, Sharma P. Goswami S, et al. Among authors: yadav ss. Nat Med. 2020 Jan;26(1):39-46. doi: 10.1038/s41591-019-0694-x. Epub 2019 Dec 23. Nat Med. 2020. PMID: 31873309 Free PMC article.
Stem cell-based therapies for HIV/AIDS.
Pernet O, Yadav SS, An DS. Pernet O, et al. Among authors: yadav ss. Adv Drug Deliv Rev. 2016 Aug 1;103:187-201. doi: 10.1016/j.addr.2016.04.027. Epub 2016 May 2. Adv Drug Deliv Rev. 2016. PMID: 27151309 Free PMC article. Review.
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.
Gao J, Navai N, Alhalabi O, Siefker-Radtke A, Campbell MT, Tidwell RS, Guo CC, Kamat AM, Matin SF, Araujo JC, Shah AY, Msaouel P, Corn P, Wang J, Papadopoulos JN, Yadav SS, Blando JM, Duan F, Basu S, Liu W, Shen Y, Zhang Y, Macaluso MD, Wang Y, Chen J, Zhang J, Futreal A, Dinney C, Allison JP, Goswami S, Sharma P. Gao J, et al. Among authors: yadav ss. Nat Med. 2020 Dec;26(12):1845-1851. doi: 10.1038/s41591-020-1086-y. Epub 2020 Oct 12. Nat Med. 2020. PMID: 33046869 Clinical Trial.
Inflammation and Prostate Cancer.
Tewari AK, Stockert JA, Yadav SS, Yadav KK, Khan I. Tewari AK, et al. Among authors: yadav ss. Adv Exp Med Biol. 2018;1095:41-65. doi: 10.1007/978-3-319-95693-0_3. Adv Exp Med Biol. 2018. PMID: 30229548 Review.
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.
Cascone T, Weissferdt A, Godoy MCB, William WN Jr, Leung CH, Lin HY, Basu S, Yadav SS, Pataer A, Mitchell KG, Khan MAW, Shi Y, Haymaker C, Solis LM, Parra ER, Kadara H, Wistuba II, Sharma P, Allison JP, Ajami NJ, Wargo JA, Jenq RR, Gibbons DL, Lee JJ, Swisher SG, Vaporciyan AA, Heymach JV, Sepesi B. Cascone T, et al. Among authors: yadav ss. Nat Commun. 2021 Aug 19;12(1):5045. doi: 10.1038/s41467-021-25188-0. Nat Commun. 2021. PMID: 34413300 Free PMC article. Clinical Trial.
Intratumor heterogeneity in prostate cancer.
Yadav SS, Stockert JA, Hackert V, Yadav KK, Tewari AK. Yadav SS, et al. Urol Oncol. 2018 Aug;36(8):349-360. doi: 10.1016/j.urolonc.2018.05.008. Epub 2018 Jun 7. Urol Oncol. 2018. PMID: 29887240 Review.
Heterogeneity in renal cell carcinoma.
Beksac AT, Paulucci DJ, Blum KA, Yadav SS, Sfakianos JP, Badani KK. Beksac AT, et al. Among authors: yadav ss. Urol Oncol. 2017 Aug;35(8):507-515. doi: 10.1016/j.urolonc.2017.05.006. Epub 2017 May 24. Urol Oncol. 2017. PMID: 28551412 Review.
258 results